Short answer · Medically reviewed summary · Last updated: 2026-04-07
Cystinosis is a rare metabolic disorder caused by mutations in the CTNS gene, which prevent the body from effectively transporting the amino acid cystine out of the lysosomes within cells. The Genetic Basis of Cystinosis At the root of Cystinosis is a genetic error. Every individual has two copies of the CTNS gene, which provides instructions for making a protein called cystinosin.
1 people with Cystinosis have shared their first-person experience on this question at DiseaseMaps.
Cystinosis is a rare metabolic disorder caused by mutations in the CTNS gene, which prevent the body from effectively transporting the amino acid cystine out of the lysosomes within cells.
At the root of Cystinosis is a genetic error. Every individual has two copies of the CTNS gene, which provides instructions for making a protein called cystinosin. Think of cystinosin as a tiny "gatekeeper" or transport pump located on the membrane of lysosomes—the cell's recycling centers. In people with Cystinosis, these mutations cause the gatekeeper to malfunction or disappear entirely. Without a working pump, the amino acid cystine becomes trapped inside the lysosome, where it crystallizes like jagged shards of glass. Over time, these crystals damage the cells, particularly in the kidneys and eyes.
Cystinosis is inherited in an autosomal recessive pattern. This means an affected individual must inherit one mutated copy of the CTNS gene from each parent. Parents are typically "carriers" who do not show symptoms because they have one healthy copy of the gene to compensate for the faulty one. There are no known environmental triggers, infectious agents, or autoimmune factors that cause the disease; it is strictly an inherited metabolic condition.
While the underlying genetic cause of Cystinosis is well-understood, medical researchers are actively investigating why the severity of the disease varies so significantly between patients, even those with similar genetic profiles. Ongoing research is focused on gene therapy, where scientists aim to introduce functional copies of the CTNS gene into a patient's own hematopoietic stem cells. By "reprogramming" these cells to produce functional cystinosin, researchers hope to provide a long-term solution that prevents the accumulation of cystine crystals throughout the body.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.